Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-035382
Filing Date
2023-03-22
Accepted
2023-03-22 08:21:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2310202d1_424b5.htm 424B5 8688
2 GRAPHIC tm2310202d1_424b5img001.jpg GRAPHIC 8345
  Complete submission text file 0001104659-23-035382.txt   21573
Mailing Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032
Business Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-258687 | Film No.: 23751475
SIC: 2834 Pharmaceutical Preparations